all times to the PI and co-investigators to review.
The PI has constituted a data and safety monitoring board (DSMB) consisting of a Professor of Epidemiology, Professor of Bio-statistician, and an Associate Professor of HIV Psychiatry to assist in the independent review of data, in particular, data concerning accrual, drop-outs, protocol deviations and adverse events. The PI and co-investigators review adverse effects (AEs) individually in real-time and in aggregate on a monthly basis. The PI and coinvestigators review serious adverse events (SAEs), such as sudden deaths, attempted suicide in real-time and this is entered into the SAE forms and submitted to both the DSMB the research ethics committee for review. The PI ensures all protocol deviations, AEs, and SAEs are reported to the DSMB and relevant IRBs according to the applicable regulatory requirements.
Collection and Reporting of SAES and AES:
For this study, the following standard AE definitions are used:
Adverse event: Any unfavorable and unintended sign or symptom associated with the participation in group support psychotherapy, regardless of whether it is considered related to the therapy. Serious Adverse Event: Any AE that results in any of the following outcomes: The study uses the following AE attribution scale:
Not related: The AE is clearly not related to the study procedures (i.e., another cause of the event is most plausible and/or a clinically plausible temporal sequence is inconsistent with the onset of the event). Possibly related: An event that follows a reasonable temporal sequence from the initiation of study procedures, but that could readily have been produced by a number of other factors. Related: The AE is clearly related to the study procedures.
During participant recruitment, all participants received a suicide risk assessment and those with high suicide risk were not eligible to participate in the study. Group facilitators were asked to check in on participant's feelings and thoughts at the start of each group session with the aim of eliciting suicidal thoughts. Any suicidal thoughts were addressed in the group discussion. If a group member did not return for a session, a group member was tasked to check on the patient and report on his or her condition in the next meeting. SAEs and specific therapy-associated AEs are reported to the DSMB and the School of Health Sciences
Research and Ethics Committee which is overseeing the study.
Management of Risks to Subjects
Expected AEs associated with this study would be suicide attempts due to lack of treatment response to the group support psychotherapy. During participant recruitment, all participants received a suicide risk assessment (Patterson et al's 1983 Evaluation of suicidal patients: the SAD PERSONS scale). Individuals with depression with high suicide risk were excluded from the study. Those with a low to moderate risk were included, their thoughts were assessed at every group meeting and care givers were asked to keep close watch on the affected individual. If suicidal thoughts were still present after 4 sessions of GSP or GHE, these individuals were referred to a mental health worker.
STOPPING RULES:
Persistent suicide thoughts or attempt is the main adverse event and safety issue in the study. Previous studies that 15-20% of patients with depression commit suicide. The incidence of persistent suicide thoughts or attempt will be compared across treatment arms that is: Number of patients referred because of persistent suicide thoughts within 90-days of randomization and number of suicide attempts occurring within 90-days of randomization. If there is a significant difference between the two groups, the trial will be stopped at that point and all patents in the control group will receive group support psychotherapy. If there are no significant differences the trial continues until 6 months after the end of group support psychotherapy sessions.
Study governance structure
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